Shedding light on the enigma of myocardial lipotoxicity: the involvement of known and putative regulators of fatty acid storage and mobilization

被引:82
作者
Brindley, David N. [1 ]
Kok, Bernard P. C. [1 ]
Kienesberger, Petra C. [2 ]
Lehner, Richard [3 ]
Dyck, Jason R. B. [2 ]
机构
[1] Univ Alberta, Dept Biochem, Signal Transduct Res Grp, Edmonton, AB T6G 2S2, Canada
[2] Univ Alberta, Dept Pediat, Cardiovasc Res Ctr, Edmonton, AB T6G 2S2, Canada
[3] Univ Alberta, Grp Mol & Cell Biol Lipids, Sch Mol & Syst Med, Edmonton, AB T6G 2S2, Canada
来源
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM | 2010年 / 298卷 / 05期
基金
加拿大健康研究院;
关键词
ceramides; energy partitioning; fatty acid oxidation; insulin resistance; HORMONE-SENSITIVE LIPASE; INDUCED INSULIN-RESISTANCE; ACTIVATED RECEPTOR-ALPHA; NECROSIS-FACTOR-ALPHA; ENDOPLASMIC-RETICULUM STRESS; PALMITATE-INDUCED APOPTOSIS; REDUCED CARDIAC EFFICIENCY; LEFT-VENTRICULAR FUNCTION; VERY-LOW-DENSITY; PPAR-ALPHA;
D O I
10.1152/ajpendo.00509.2009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Brindley DN, Kok BP, Kienesberger PC, Lehner R, Dyck JR. Shedding light on the enigma of myocardial lipotoxicity: the involvement of known and putative regulators of fatty acid storage and mobilization. Am J Physiol Endocrinol Metab 298: E897-E908, 2010. First published January 26, 2010; doi: 10.1152/ajpendo.00509.2009.-Excessive fatty acid (FA) uptake by cardiac myocytes is often associated with adverse changes in cardiac function. This is especially evident in diabetic individuals, where increased intramyocardial triacylglycerol (TG) resulting from the exposure to high levels of circulating FA has been proposed to be a major contributor to diabetic cardiomyopathy. At present, our knowledge of how the heart regulates FA storage in TG and the hydrolysis of this TG is limited. This review concentrates on what is known about TG turnover within the heart and how this is likely to be regulated by extrapolating results from other tissues. We also assess the evidence as to whether increased TG accumulation protects against FA-induced lipotoxicity through limiting the accumulations of ceramides and diacylglycerols versus whether it is a maladaptive response that contributes to cardiac dysfunction.
引用
收藏
页码:E897 / E908
页数:12
相关论文
共 178 条
[1]   Effect of BM 17.0744, a PPARα ligand, on the metabolism of perfused hearts from control and diabetic mice [J].
Aasum, E ;
Cooper, M ;
Severson, DL ;
Larsen, TS .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2005, 83 (02) :183-190
[2]   Fenofibrate modulates cardiac and hepatic metabolism and increases ischemic tolerance in diet-induced obese mice [J].
Aasum, Ellen ;
Khalid, Ahmed Murtaz ;
Gudbrandsen, Oddrun Anita ;
How, Ole-Jakob ;
Berge, Rolf K. ;
Larsen, Terje S. .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2008, 44 (01) :201-209
[3]   Cardiac remodeling in obesity [J].
Abel, E. Dale ;
Litwin, Sheldon E. ;
Sweeney, Gary .
PHYSIOLOGICAL REVIEWS, 2008, 88 (02) :389-419
[4]   Effect of Fibrates on Lipid Profiles and Cardiovascular Outcomes: A Systematic Review [J].
Abourbih, Samuel ;
Filion, Kristian B. ;
Joseph, Lawrence ;
Schiffrin, Ernesto L. ;
Rinfret, Stephane ;
Poirier, Paul ;
Pilote, Louise ;
Genest, Jacques ;
Eisenberg, Mark J. .
AMERICAN JOURNAL OF MEDICINE, 2009, 122 (10) :962.e1-962.e8
[5]  
Baranowski M, 2007, J PHYSIOL PHARMACOL, V58, P57
[6]   PPAR signaling in the control of cardiac energy metabolism [J].
Barger, PM ;
Kelly, DP .
TRENDS IN CARDIOVASCULAR MEDICINE, 2000, 10 (06) :238-245
[7]   Cardiac Expression of Microsomal Triglyceride Transfer Protein Is Increased in Obesity and Serves to Attenuate Cardiac Triglyceride Accumulation [J].
Bartels, Emil D. ;
Nielsen, Jan M. ;
Hellgren, Lars I. ;
Ploug, Thorkil ;
Nielsen, Lars B. .
PLOS ONE, 2009, 4 (04)
[8]   Cardioprotective properties of fibrates - Which fibrate, which patients, what mechanism? [J].
Barter, PJ ;
Rye, KA .
CIRCULATION, 2006, 113 (12) :1553-1555
[9]   Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: Peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach [J].
Bays, H ;
Mandarino, L ;
DeFronzo, RA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (02) :463-478
[10]  
Bielawska AE, 1997, AM J PATHOL, V151, P1257